￥420 million fine eyed for 3 drug wholesalers
17:29 JST, February 7, 2022
TOKYO (Jiji Press) — Japan’s Fair Trade Commission plans to order three major drug wholesalers to pay a total of about ¥420 million in fines for rigging bids for contracts to supply ethical drugs to an independent administrative body, according to informed sources.
The three companies found to have violated the antimonopoly law are Alfresa Corp., Toho Pharmaceutical Co. and Suzuken Co.
The FTC will also urge the companies to take measures to prevent a recurrence of such wrongdoing, the sources said Sunday.
Late last month, the commission notified the companies of the punishment plan. It will make a final decision after hearing opinions from them.
In November 2019, the FTC raided the three companies and Mediceo Corp.
The Tokyo District Public Prosecutors Office’s special investigation team indicted Alfresa and Toho, both based in Tokyo, as well as Suzuken, headquartered in Nagoya. Tokyo-based Mediceo was exempted from indictment as the company voluntarily reported the bid-rigging.
"NEWS SERVICES" POPULAR ARTICLE
Russia summons heads of U.S. media outlets, warns of ‘stringent measures’
Ukraine’s volunteer ‘Kraken’ unit takes the fight to the Russians
Leaders pledge arms and EU path for Ukraine in Kyiv visit
China secretly building PLA naval facility in Cambodia, Western officials say
Russian missile strike hits crowded shopping mall in Ukraine
JN ACCESS RANKING
- Japan, Finland confirm unity in dealing with Russia
- Mangaka Fujiko Fujio A dies at 88
- China’s aircraft carrier drills near Japan aimed at around-the-clock attack capability
- As wheat prices soar, Japanese food industry pushes rice flour as alternative
- Fukushima lab releases images of ‘highly likely’ UFOs